An international research team, with significant involvement from the Medical University of Vienna, has developed a new AI-based analysis method that can accurately classify brain tumors using genetic ...

St. Jude Children’s Research Hospital scientists and multinational collaborators created AI-powered M-PACT to facilitate next-generation classification of pediatric brain tumors by liquid biopsy.

Meningioma is the most common type of brain tumor. It does not develop in the brain tissue itself, but on the inside of the ...

BrainIAC, a breakthrough AI foundation model, is able to predict brain age, dementia, time-to-stroke, and brain cancer from brain magnetic resonance imaging (MRI).

Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning algorithms, ClairS-TO and Clair3-RNA, that significantly advance genetic ...

AI is transforming oncology by improving early detection, diagnosis, and treatment personalization through advanced data analysis and machine learning. In imaging, AI systems have demonstrated ...

A tool for spotting pancreatic cancer in routine CT scans has had promising results, one example of how China is racing to apply A.I. to medicine’s tough problems. Self-service kiosks at the ...

A mom was diagnosed with brain cancer after the tingling in her arm was dismissed as anxiety. Kelsey Stokstad, 32, started experiencing numbness and tingling in her left arm and hand but doctors told ...

Nasal drops may offer a new non-invasive way to help the body fight aggressive and deadly brain cancers. Researchers at Washington University School of Medicine and Northwestern University have ...

A new nasal-delivered nanotherapy shows promise against aggressive glioblastoma tumors. By activating the STING immune pathway using gold-core spherical nucleic acids, researchers were able to reach ...

“I was constantly being told by my GP that it was in my head,” said Karen Tait The Brain Tumour Charity/Karen Tait / SWNS Karen Tait started experiencing severe symptoms in October 2022 that left her ...

Remission of TP53-Mutant AML After Transplantation With Trem-Cel, a CRISPR/Cas9 Gene-Edited Allograft Lacking CD33, Followed by a Donor-Derived Anti-CD33 Chimeric Antigen Receptor T (VCAR33) The ...